Presenters
Section Head, Nuclear Cardiology
Dr. Edward-Bengie Magsombol
Course Details
- This is a 40-minute webinar dedicated to pharmacists. It described the pathophysiology of hypertension and the drugs used to treat this condition. The webinar features Dr. Edward Bengie Magsombol as speaker.
- Duration: 40:49 min.
- CPD Points: 0.5
- Program Number: PROG-2024-75942
Telmisartan: Management of Hypertension and the Role of the Pharmacist by Dr. Edward-Bengie Magsombol Course Outline
- What is Hypertension
- How common is hypertension
- Patients with controlled blood pressure
- What causes hypertension?
- The renin-angiotensin-aldosterone system
- 2018 ECS guidelines on hypertension
- 2020 Clinical Practice Guidelines for the Management of Hypertension in the Philippines
- Drug-related causes of poor BP control
- Angiotensin-converting enzyme inhibitors
- Angiotensin receptor blockers
- Angiotensin receptor blocker: Valsartan
- Angiotensin receptor blocker: Irbesartan
- Angiotensin receptor blocker: Losartan
- Angiotensin receptor blocker: Telmisartan
- Unique features of Telmisartan, by Boehringer Ingelheim
- Advancement of Telmisartan in the Philippines
- Single-pill combination: telmisartan + amlodipine
- Efficacy: Telmisartan + amlodipine
- Safety: Telmisartan + amlodipine
- The role of the Philippine pharmacist in hypertension management
- Effect of healthcare intervention on hypertension management
- Who is the hypertensive patient at high risk?
- RAAS inhibitors for high-risk hypertensive patients
- Pathophysiology of hypertension and diabetes
- 2020 Philippine CPGs on hypertension
- Losartan in patients with diabetes mellitus
- Telmisartan is the only ARB proven and indicated to provide CV protection for high-risk patients 1-3 MALIIT SA TAAS
- Pharmaceutical counselling
- Hypertension and CKD: Related risk factors
- Goals of hypertension treatment in chronic kidney disease
- 2020 Philippine Hypertension CPG: CKD-specific recommendations
- Renal benefit of ARBs: Valsartan
- Renal benefit of ARBs: Irbesartan
- Renal benefit of ARBs: Losartan
- Renal benefit of ARBs: Telmisartan
- Telmisartan is efficient along the renal continuum for patient with diabetes
- Nephrotoxicity in CKD-HTN medications
- Dose adjustments in CKD-HTN medications
- Drug-drug interactions in CKD-HTN medications